Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020
Go back to Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020| Gilead Sciences (NASDAQ: GILD) | Delayed: 131.20 +1.89 (1.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $129.31 | 52 Week High | $108.63 | |||
| Open | $131.00 | 52 Week Low | $71.39 | |||
| Day High | $133.06 | P/E | 72.49 | |||
| Day Low | $129.43 | EPS | $1.81 | |||
| Volume | 2,982,510 | |||||

